2021
DOI: 10.1002/chem.202103926
|View full text |Cite
|
Sign up to set email alerts
|

Direct Superacid‐Promoted Difluoroethylation of Aromatics

Abstract: Under superacid conditions, aromatic amines are directly and regioselectively 1,1-difluoroethylated. Low temperature in situ NMR studies confirmed the presence of benzylic α-fluoronium and α-chloronium ions as key inter-mediates in the reaction. This method has a wide substrate scope and can be applied to the late-stage functionalization of natural alkaloids and active pharmaceutical ingredients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 47 publications
0
3
0
Order By: Relevance
“…Finally, we assume that the strongest bond in organic chemistry [1] is further strengthened due to the protonation of the acyl fluoride moiety, based on the resonance stabilization of the carbon–fluorine bond. This is especially reinforced for analogous diprotonated superelectrophiles [37] …”
Section: Resultsmentioning
confidence: 91%
See 1 more Smart Citation
“…Finally, we assume that the strongest bond in organic chemistry [1] is further strengthened due to the protonation of the acyl fluoride moiety, based on the resonance stabilization of the carbon–fluorine bond. This is especially reinforced for analogous diprotonated superelectrophiles [37] …”
Section: Resultsmentioning
confidence: 91%
“…This Chemistry-A European Journal is especially reinforced for analogous diprotonated superelectrophiles. [37]…”
Section: Chemistry-a European Journalmentioning
confidence: 99%
“…Currently, 30 is in phase I/Ib trial to evaluate its efficacy in advanced or metastatic ERα+ breast cancer ( Scott and Barlaam, 2022 ). Preliminary results show that 30 is well-tolerated and has a manageable safety profile ( Artault et al, 2022 ). However, poor metabolic stability and low ERα degradation activity in vivo have led to unsatisfactory results in phase I trials.…”
Section: Serdsmentioning
confidence: 99%